Fuqiang Liu Selected Research

Fuqiang Liu Research Topics

Disease

12	Type 2 Diabetes Mellitus (MODY) 09/2023 - 01/2014
11	Neoplasms (Cancer) 01/2024 - 01/2009
9	Insulin Resistance 11/2023 - 06/2013
8	Hypertension (High Blood Pressure) 01/2021 - 10/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2021
5	Inflammation (Inflammations) 11/2023 - 04/2012
4	Wounds and Injuries (Trauma) 04/2024 - 01/2019
3	Hyperlipidemias (Hyperlipidemia) 11/2023 - 01/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2021
3	Dyslipidemias (Dyslipidemia) 01/2022 - 09/2014
3	Atherosclerosis 01/2022 - 01/2013
3	Diabetes Mellitus 08/2021 - 12/2017
3	Infections 09/2014 - 01/2009
2	Heart Failure 04/2023 - 01/2023
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2015
2	Atrial Fibrillation 01/2023 - 01/2012
2	COVID-19 04/2022 - 12/2021
2	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2013
2	Hyperglycemia 11/2021 - 09/2014
2	Myocardial Infarction 01/2021 - 05/2018
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 08/2016
2	Acute Coronary Syndrome 11/2020 - 08/2020
2	Stomach Neoplasms (Stomach Cancer) 03/2015 - 05/2013
2	Essential Hypertension 09/2012 - 10/2011
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2024
1	Hypotension (Low Blood Pressure) 01/2024
1	Liver Diseases (Liver Disease) 11/2023
1	Fatty Liver 11/2023
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 09/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2023
1	Coronary Disease (Coronary Heart Disease) 03/2023
1	Drug-Related Side Effects and Adverse Reactions 03/2023
1	Acute Kidney Injury (Acute Renal Failure) 03/2023
1	Atrophy 01/2023
1	Muscular Atrophy (Muscle Atrophy) 01/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022
1	Patent Foramen Ovale 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Hypertriglyceridemia 01/2022
1	Aortic Dissection 01/2022
1	Ischemic Stroke 01/2022

Drug/Important Bio-Agent (IBA)

9	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2014
5	SaltsIBA 02/2024 - 10/2011
4	Insulin (Novolin)FDA Link 11/2021 - 09/2014
3	LipidsIBA 12/2021 - 01/2020
3	EnzymesIBA 05/2018 - 01/2013
2	Uric Acid (Urate)IBA 01/2024 - 09/2017
2	NisinIBA 05/2023 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2013
2	CytokinesIBA 01/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2021
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2009
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2009
2	Advanced Glycation End ProductsIBA 01/2022 - 12/2017
2	Small Interfering RNA (siRNA)IBA 11/2021 - 05/2013
2	Messenger RNA (mRNA)IBA 11/2021 - 01/2020
2	Hypoglycemic Agents (Hypoglycemics)IBA 08/2021 - 01/2015
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2021 - 01/2016
2	PotassiumIBA 04/2021 - 01/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 08/2016
2	Circular RNAIBA 01/2021 - 01/2020
2	omega-Chloroacetophenone (Mace)IBA 11/2020 - 08/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2020 - 08/2020
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2020 - 01/2013
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2014
2	Peptides (Polypeptides)IBA 01/2019 - 06/2013
2	C-PeptideIBA 01/2016 - 01/2015
2	Moclobemide (Arima)IBA 12/2015 - 11/2014
1	PowdersIBA 04/2024
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2024
1	puerarinIBA 11/2023
1	Sirtuin 1IBA 11/2023
1	Metformin (Glucophage)FDA LinkGeneric 09/2023
1	vericiguatIBA 04/2023
1	Probucol (Lorelco)FDA Link 03/2023
1	Serine-Threonine Kinase 3IBA 01/2023
1	baysilon (polydimethylsiloxane)IBA 01/2023
1	Sincalide FDA Link 01/2023
1	3-methyladenineIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 09/2022
1	AnticoagulantsIBA 04/2022
1	Guanosine Diphosphate (GDP)IBA 01/2022
1	Caspase 9IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2022
1	Toll-Like Receptor 4IBA 01/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 01/2022

Therapy/Procedure

7	Therapeutics 01/2023 - 01/2020
2	Secondary Prevention 11/2020 - 08/2020
1	General Anesthesia 01/2024
1	Controlled Hypotension 01/2024
1	Duration of Therapy 09/2023
1	Length of Stay 03/2023
1	Percutaneous Coronary Intervention 03/2023
1	Critical Care (Surgical Intensive Care) 04/2022
1	Immunotherapy 01/2022